Target: TUBA8 (Tubulin Alpha 8), encoded by the TUBA8 gene (HGNC ID: 51807), is involved in microtubule dynamics and cellular processes like division and motility .
Buffer: Ascitic fluid with 0.03% sodium azide (requires careful handling) .
Storage: Stable at 4°C short-term; -20°C for long-term preservation .
Mutations in TUBA8 are linked to polymicrogyria with optic nerve hypoplasia, a cortical malformation disorder. Studies show TUBA8 dysfunction disrupts microtubule stability, impairing neuronal migration and brain development .
Hepatocellular Carcinoma (HCC): TUBA8 overexpression in Huh7 cells inhibits growth but enhances migration in HepG2 cells, indicating cell-specific roles in tumorigenesis .
Immune Dysregulation: In ankylosing spondylitis (AS) with femoral head necrosis, TUBA8 correlates with macrophage M0 and mast cell activity, suggesting roles in immune-mediated tissue damage .
TUBA8 expression levels influence sensitivity to chemotherapeutics:
Diagnostic Use: Detects TUBA8 in pathological tissues (e.g., brain or liver biopsies) .
Mechanistic Studies: Elucidates TUBA8’s role in microtubule dynamics and post-translational modifications .
Therapeutic Targeting: Investigated for modulating TUBA8 to alter cancer cell proliferation or immune responses .
TUBA8 is a member of the alpha tubulin family that shows the highest divergence among all alpha tubulins. It is primarily expressed in testis and muscle tissues, with lower levels in the brain . TUBA8 is of particular interest because it uniquely lacks two key post-translational modification sites that are present in other alpha tubulins, suggesting specialized functions . Research interest in TUBA8 has increased following the identification of TUBA8 mutations in human subjects with polymicrogyria syndrome, indicating its potential involvement in cerebral cortex development .
Several types of TUBA8 antibodies are available for research purposes:
TUBA8 antibodies can be used in multiple experimental applications:
Western Blotting (WB): For detecting TUBA8 protein in tissue or cell lysates. Most commercial antibodies are validated for this application .
Immunohistochemistry (IHC): For localizing TUBA8 in tissue sections, particularly useful for studying expression in brain and testis .
Immunofluorescence (IF): For visualizing TUBA8 localization at the subcellular level .
Flow Cytometry (FACS): For quantifying TUBA8 expression in cell populations .
Immunoprecipitation (IP): For isolating TUBA8 protein complexes to study interactions .
Methodology note: The choice of antibody should be guided by the specific experimental application and target tissue. For example, when studying brain tissue, the custom monoclonal against amino acids 35-45 has shown good specificity for detecting TUBA8 in cerebellar Purkinje cells .
Validating antibody specificity is crucial for reliable research results. Based on the approaches in the literature:
Use of knockout models: The most rigorous validation method is testing the antibody in TUBA8 knockout tissues. Researchers have confirmed antibody specificity by demonstrating absence of staining in Tuba8 knockout mouse tissues .
Western blot analysis: Verify the antibody detects a single band of the expected molecular weight (~50 kDa for TUBA8). Compare expression levels between tissues known to have high (testis) versus low (brain) expression .
Immunohistochemical comparison: Compare staining patterns in control versus knockout tissues. In the cerebellum, specific Tuba8 staining is observed in Purkinje cell dendrites in control animals but shows reduced intensity in knockout animals .
RNA correlation: Correlate protein expression detected by the antibody with mRNA levels determined by quantitative PCR to ensure concordance .
Cerebellar localization: In mouse brain, TUBA8 specifically localizes to cerebellar Purkinje cells rather than showing widespread cortical expression .
Knockout phenotype: Surprisingly, TUBA8 knockout mice did not display PMG or other obvious neurological abnormalities despite the absence of TUBA8 protein .
Genetic reassessment: Exome sequencing of human PMG patients initially thought to have disease-causing TUBA8 mutations revealed an additional homozygous frameshift mutation in SNAP29 (c.487dupA, p.Ser163Lysfs*6), which likely accounts for the PMG phenotype . SNAP29 mutations are known to cause CEDNIK syndrome, which includes PMG.
Cortical development: More recent studies suggest TUBA8 may play a role in the differentiation of radial glial cells (RGs) into apical intermediate progenitors (aIPs). Overexpression of TUBA8 increased the percentage of pTα+ cells (a marker of aIPs), while knockdown or knockout showed a reduction in these cells .
These findings suggest TUBA8 may have subtle but specific roles in brain development that warrant further investigation, particularly in cerebellar function and cortical differentiation pathways.
TUBA8 shows its highest expression in testis, where it exhibits a specific localization pattern during spermatogenesis:
Stage-specific expression: TUBA8 expression is restricted to certain stages of spermiogenesis in the testis .
Subcellular localization: In developing spermatids, TUBA8 initially shows strong acrosomal localization that gradually shifts to a cytoplasmic distribution as development progresses .
Absence in mature sperm: TUBA8 is absent from mature spermatozoa, suggesting its role is specific to developmental stages rather than being a structural component of the mature flagellum .
Fertility impact: Despite the high expression and specific localization pattern, TUBA8 knockout mice remained fertile, indicating TUBA8 is not essential for fertility under laboratory conditions .
Immunohistochemical analysis reveals strong TUBA8 presence peripheral to the nucleus in wild-type testis but not in knockout tissue . This suggests TUBA8 may have a role in spermatid development during spermatogenesis rather than functioning as a component of the microtubule-rich flagellum itself.
TUBA8 stands out among alpha tubulins due to several unique features:
Sequence divergence: TUBA8 is the most divergent member of the highly conserved alpha tubulin family .
Post-translational modification sites: TUBA8 uniquely lacks two key post-translational modification sites that are present in other alpha tubulins . This likely affects its regulation and function.
Expression pattern: Unlike more ubiquitously expressed alpha tubulins (like TUBA1A), TUBA8 shows tissue-specific expression, being most abundant in testis and muscle with lower levels in the brain .
Evolutionary conservation: Alpha tubulins are generally highly conserved across species, with multiple genes (six in humans) coding for different isotypes . TUBA8's divergent nature suggests it may have evolved specialized functions.
When studying TUBA8 in relation to other tubulins, researchers should consider using specific antibodies that recognize TUBA8's unique epitopes to avoid cross-reactivity with more abundant alpha tubulin isotypes. For comparison studies, antibodies targeting post-translational modifications like tyrosination (recognized by YL1/2 clone) or acetylation (recognized by 6-11B-1 clone) can be used alongside TUBA8-specific antibodies .
Detecting TUBA8 in tissues with low expression levels (like brain) requires optimized methods:
Antibody selection: For low-abundance detection, highly specific monoclonal antibodies are recommended. The custom monoclonal antibody generated against amino acids 35-45 (TFGTQASKIND) of murine Tuba8 has demonstrated good specificity in detecting low levels of expression .
Signal amplification techniques:
Antigen retrieval: Proper antigen retrieval (e.g., using 10 mM citrate buffer, pH 6.0) is essential for detecting low-abundance proteins in formalin-fixed, paraffin-embedded tissues .
Western blot optimization:
Transcript analysis: For very low protein levels, quantitative reverse transcription PCR can be a more sensitive alternative to detect TUBA8 expression, using DNaseI treatment of RNA prior to cDNA synthesis .
Knockout controls: Always include knockout tissue as a negative control to distinguish specific staining from background, particularly important when detecting low-abundance proteins .
Differentiating TUBA8 from other more abundant alpha tubulins requires careful experimental design:
Antibody selection: Use antibodies raised against the most divergent regions of TUBA8. The custom monoclonal targeting amino acids 35-45 (TFGTQASKIND) specifically recognizes this divergent region in exon 2 .
Expression analysis: Compare expression patterns with known TUBA8 distribution (high in testis, moderate in muscle, low in brain) versus more ubiquitous tubulin isotypes.
Post-translational modification comparison:
Genetic approaches:
Subcellular localization: Map the specific subcellular distribution of TUBA8 (e.g., strong in Purkinje cell dendrites in cerebellum, acrosomal in developing spermatids) which can differ from other tubulins .
The immunohistochemical comparison of TUBA8, tyrosinated alpha tubulin, and acetylated alpha tubulin in testis tissues from control and knockout animals demonstrates how these different tubulin variants can be distinguished based on their localization patterns .
Based on the research literature, several experimental models have proven valuable for TUBA8 studies:
TUBA8 knockout mice: A conditional knockout mouse model with deletion of exon 3 has been generated and characterized. This model shows complete absence of TUBA8 protein and is viable, making it useful for studying TUBA8 function in various tissues .
In utero electroporation: For studying TUBA8's role in cortical development, in utero electroporation of TUBA8 overexpression or knockdown constructs has been effective in examining effects on radial glia differentiation .
Tissue-specific analysis: Given TUBA8's differential expression, tissue-specific approaches are recommended:
Developmental time points: When studying brain development, examining multiple embryonic (E18.5) and postnatal (P10) time points is important as TUBA8's role may vary during development .
Cellular models: For studying TUBA8's role in radial glia differentiation, cortical progenitor cultures with markers like Blbp and Tα can be used alongside genetic manipulation of TUBA8 .
The apparent discrepancy between severe phenotypes in human patients with TUBA8 mutations and the lack of obvious neurological abnormalities in TUBA8 knockout mice requires careful interpretation:
Re-evaluate genetic findings: When clinical phenotypes don't match experimental models, consider whole exome sequencing to identify additional mutations. In the case of TUBA8, researchers discovered that PMG patients also carried a homozygous frameshift mutation in SNAP29, which likely explained their neurological phenotype .
Consider species differences:
Human TUBA8 and mouse Tuba8 may have evolved different functions or redundancies with other tubulins.
Expression patterns may differ between species despite sequence conservation.
Examine subtle phenotypes: Though gross neurological abnormalities were absent in knockout mice, subtle defects in Purkinje cell dendrites were observed, suggesting more sensitive assays may be needed to detect functional consequences .
Investigate compensatory mechanisms: Other tubulin isotypes may compensate for TUBA8 loss in knockout models. Analyze expression of other tubulins in the knockout tissues.
Consider environmental factors: Laboratory conditions may not expose phenotypes that would manifest under environmental stress or over longer timeframes.
Functional redundancy: The family of alpha tubulins shows functional overlap. For example, despite high expression in testis and specific localization during spermatogenesis, TUBA8 knockout mice remained fertile, suggesting redundancy .
To ensure reliable results when using TUBA8 antibodies, implement these controls:
Genetic knockout controls: Tissues from TUBA8 knockout animals provide the most definitive negative control for antibody specificity testing .
Positive tissue controls: Include tissues known to express high levels of TUBA8 (testis) as positive controls alongside experimental samples .
Isotype controls: Include appropriate isotype control antibodies (e.g., IgG2a for the 2G6 monoclonal) to identify non-specific binding .
Comparative labeling: Run parallel staining with antibodies to post-translationally modified tubulins (acetylated, tyrosinated) to compare distribution patterns .
Antibody validation panels: Test multiple antibodies targeting different epitopes of TUBA8 on the same samples to confirm consistent localization patterns .
RNA correlation: Correlate protein detection with mRNA expression data from RT-qPCR to confirm expression patterns match at both RNA and protein levels .
Secondary antibody only controls: Include controls with no primary antibody to identify non-specific secondary antibody binding.
Blocking peptide competition: If available, pre-absorb the antibody with the immunizing peptide to demonstrate specificity of the staining pattern.
In the TUBA8 knockout mouse studies, researchers effectively demonstrated antibody specificity by comparing cerebellar Purkinje cell staining between control and knockout tissues, showing reduced intensity in the knockout despite some background labeling .
Despite the reevaluation of TUBA8's direct role in PMG, TUBA8 antibodies remain valuable tools for studying neurodevelopment:
Cerebellar development studies: Given TUBA8's specific expression in Purkinje cell dendrites, TUBA8 antibodies can be used to study dendritic development and remodeling in the cerebellum .
Radial glia differentiation: TUBA8 antibodies can be used alongside markers like Blbp and Tα to study the transition of radial glia into apical intermediate progenitors during cortical development .
Methodological approach:
Use E12.5-E18.5 embryonic stages to study developing cortex
Combine with markers of radial glia (Blbp, Glast) and intermediate progenitors (Tα)
Compare expression patterns between wildtype and Tuba8KO tissues
Correlate protein expression with RT-qPCR quantification of transcripts
Developmental time course: TUBA8 antibodies can track expression changes during development, as seen in the finding that Tuba8KO cortices expressed significantly more Blbp at later developmental stages .
Subcellular localization studies: High-resolution imaging with TUBA8 antibodies can reveal unique subcellular distribution patterns that may suggest specialized functions in neuronal development.
Protein interaction studies: TUBA8 antibodies can be used for co-immunoprecipitation to identify binding partners that may provide insight into its neurological functions.